IP Verse

N-Acetylcysteine Compositions And Methods For The Treatment And Prevention Of Drug Toxicity

Patent No. EP1379232 (titled "N-Acetylcysteine Compositions And Methods For The Treatment And Prevention Of Drug Toxicity") was filed by Bioadvantex Pharma on Mar 28, 2002. The application was issued on Jul 29, 2015.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
OSERApr 29, 2016PRUFER & PARTNER MBB PATENTANWALTE RECHTSANWALTE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP1379232

BIOADVANTEX PHARMA
Application Number
EP02725376A
Filing Date
Mar 28, 2002
Status
Revoked
Sep 7, 2018
Publication Date
Jul 29, 2015
External Links
Slate, Register , Google Patents